We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
+2.23%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$343M
AUM Growth
+$37.4M
Cap. Flow
+$35.3M
Cap. Flow %
10.29%
Top 10 Hldgs %
41.12%
Holding
158
New
28
Increased
68
Reduced
56
Closed
3
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
51
Verizon
VZ
$182B
$1.52M 0.44%
38,030
+2,361
+7% +$99.6K
MARM icon
52
FT Vest US Equity Max Buffer ETF March
MARM
$108M
$1.51M 0.44%
49,056
-48,225
-50% -$1.48M
MCD icon
53
McDonald's
MCD
$190B
$1.49M 0.44%
5,148
+105
+2% +$31.3K
RSPT icon
54
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.38B
$1.49M 0.43%
39,849
HYG icon
55
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.47M 0.43%
18,720
-914
-5% -$72.6K
BA icon
56
Boeing
BA
$169B
$1.43M 0.42%
8,096
+1,531
+23% +$240K
META icon
57
Meta Platforms (Facebook)
META
$1.64T
$1.43M 0.42%
2,446
+439
+22% +$258K
BUXX icon
58
Strive Enhanced Income Short Maturity ETF
BUXX
$491M
$1.4M 0.41%
+68,852
New +$1.4M
TFLO icon
59
iShares Treasury Floating Rate Bond ETF
TFLO
$6.56B
$1.39M 0.41%
27,531
+16,766
+156% +$847K
CRM icon
60
Salesforce
CRM
$140B
$1.39M 0.4%
4,145
-20
-0.5% -$6.38K
TMO icon
61
Thermo Fisher Scientific
TMO
$198B
$1.3M 0.38%
2,495
+28
+1% +$15.4K
SPGP icon
62
Invesco S&P 500 GARP ETF
SPGP
$2.19B
$1.29M 0.38%
12,265
+355
+3% +$38.3K
TRV icon
63
Travelers Companies
TRV
$78.5B
$1.27M 0.37%
5,278
-55
-1% -$13.7K
VNQ icon
64
Vanguard Real Estate ETF
VNQ
$39.6B
$1.24M 0.36%
13,877
-1,052
-7% -$99.4K
XHB icon
65
State Street SPDR S&P Homebuilders ETF
XHB
$2.08B
$1.23M 0.36%
11,730
-53,806
-82% -$6.31M
VCLT icon
66
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.99B
$1.15M 0.34%
15,377
-933
-6% -$72.5K
NOC icon
67
Northrop Grumman
NOC
$74.1B
$1.09M 0.32%
2,315
+436
+23% +$219K
SGOV icon
68
iShares 0-3 Month Treasury Bond ETF
SGOV
$97.5B
$1.06M 0.31%
+10,527
New +$1.06M
TBIL
69
F/m US Treasury 3 Month Bill Fund
TBIL
$7.14B
$1.05M 0.31%
+21,091
New +$1.05M
NKE icon
70
Nike
NKE
$64.9B
$1.04M 0.3%
13,705
+3,153
+30% +$248K
USMV icon
71
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$1.04M 0.3%
11,665
-3,233
-22% -$297K
XLF icon
72
State Street Financial Select Sector SPDR ETF
XLF
$54.8B
$1.02M 0.3%
21,149
-71,347
-77% -$3.45M
FNDX icon
73
Schwab Fundamental US Large Company Index ETF
FNDX
$26.3B
$1M 0.29%
+42,247
New +$1.02M
SFLR icon
74
Innovator Equity Managed Floor ETF
SFLR
$2.09B
$960K 0.28%
29,398
+8,781
+43% +$287K
V icon
75
Visa
V
$682B
$941K 0.27%
2,976
+32
+1% +$9.62K

Similar funds

Prostatis Group's Q4 2024 Portfolio in Review

As of Q4 2024, Prostatis Group held 158 positions worth $343M, up 12% from $306M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Prostatis Group deployed $35.3M of net new capital in Q4 2024, opening 28 new positions and adding to 68 existing holdings. Its largest new stake was iShares US Financials ETF: 71,483 shares worth $7.9M.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, up from 4.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $15.2M trimmed.

  • Prostatis Group's largest Q4 2024 buy was iShares US Financials ETF: 71,483 shares worth $7.9M.
  • Prostatis Group added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2024, an estimated $17.6M increase.
  • Prostatis Group's biggest Q4 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $15.2M.
  • Prostatis Group fully exited Freeport-McMoran in Q4 2024, selling an estimated $229K.
  • Prostatis Group's ten largest holdings make up 41% of its $343M portfolio in Q4 2024.
  • Prostatis Group opened 28 new positions and closed 3 in Q4 2024.
  • Prostatis Group's portfolio value rose 12% quarter-over-quarter to $343M.

Based on Prostatis Group's 13F filing for Q4 2024, filed 21 Mar 2025.